| cpd01052 | 1144038-80-1 | | CPRGGSVC | Doxorubicin | Anticancer therapy | amide | Majumdar, Sumit;et.al (2009)
DOI |
cpd01053 | 1150100-27-8 | | KTTKS | L-Ascorbic acid | Cosmetic products and wound healing agents | amide | Choi, Ho-et.al (2009)
DOI | cpd01054 | 790294-52-9 | | KTTKS | L-Ascorbic acid | Cosmetic products and wound healing agents | amide | Choi, Ho-et.al (2009)
DOI | cpd01055 | 1155231-83-6 | Transferrin receptor binding peptide | KHAIYPRH | Artemisinin | Anticancer, leukemia | amide | Oh, Steve;et.al (2009)
DOI | cpd01056 | 1155231-82-5 | Transferrin receptor binding peptide | HAIYPRH | Artemisinin | Anticancer, leukemia | amide | Oh, Steve;et.al (2009)
DOI | cpd01057 | 1097833-59-4 | tripeptide | PID | Vinblastine | Anticancer, antimitotic | amide | Ngo, Quoc Anh;et.al (2009)
DOI | cpd01058 | 1097833-58-3 | tripeptide | PID | Vinblastine | Anticancer, antimitotic | amide | Ngo, Quoc Anh;et.al (2009)
DOI | cpd01059 | 1097833-57-2 | dipeptide | PI | Vinblastine | Anticancer, antimitotic | amide | Ngo, Quoc Anh;et.al (2009)
DOI | cpd01060 | 1097833-56-1 | dipeptide | PI | Vinblastine | Anticancer, antimitotic | amide | Ngo, Quoc Anh;et.al (2009)
DOI | cpd01061 | 1097833-53-8 | tripeptide | PID | Vinblastine | Anticancer, antimitotic | amide | Ngo, Quoc Anh;et.al (2009)
DOI | cpd01062 | 1095493-09-6 | tripeptide | RGD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01063 | 1095493-07-4 | tripeptide | RKD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01064 | 1095493-03-0 | tripeptide | RXD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01065 | 1095492-99-1 | tripeptide | RFD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01066 | 1095492-95-7 | tripeptide | RXD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01067 | 1095492-91-3 | tripeptide | RXD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01068 | 1095492-87-7 | tripeptide | RPD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01069 | 1095492-85-5 | tripeptide | RPD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01070 | 1095492-83-3 | tripeptide | RGD | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01071 | 1095492-81-1 | tetrapeptide | RGDX | (1′R,3′R,4′aS,4′bR,6′aS,8′S,10′aS,10′bS,12′aS)-1′-[1H]phenanthro[2,1-c]pyran]-3′-carboxylic acid, octadecahydro-8′-methoxy-10′a,12′a-dimethyl-Spiro[furan-2(3H) | Integrin antagonist | amide | Banerjee, Abhisek;et.al (2009)
DOI | cpd01072 | 1009811-79-3 | polyarginin | RRRRRRRR | Daunorubicine | Anticancer therapy, leukemia | amide | Banoczi, Zoltan;et.al (2008)
DOI | cpd01073 | 1009811-78-2 | polyarginin | RRRRRR | Daunorubicine | Anticancer therapy, leukemia | amide | Banoczi, Zoltan;et.al (2008)
DOI | cpd01074 | 1009811-77-1 | polyarginin | RRRR | Daunorubicine | Anticancer therapy, leukemia | amide | Banoczi, Zoltan;et.al (2008)
DOI | cpd01075 | 1073635-93-4 | | GANPNAAG | 4-[(1E)-2-[2,5-dibutoxy-4-[(1E)-2-[3,4,5-tris(dodecyloxy)phenyl]ethenyl]phenyl]ethenyl]-benzoic acid | Synthesis, possible bio-nanotechnological applications | amide | Matmour, Rachid;et.al (2008)
DOI | cpd01076 | 1067653-18-2 | | NXGPKKKRKV | N-[2-[2-oxo-2-[[4-(10,15,20-triphenyl-21H,23H-porphin-5-yl)phenyl]amino]ethoxy]acetyl]-L-Aspartic acid | Anicancer therapy, prostate | amide | Sehgal, Inder;et.al (2008)
DOI | cpd01077 | 1067653-17-1 | | GRKKRRQRRRPPQ | N-[2-[2-oxo-2-[[4-(10,15,20-triphenyl-21H,23H-porphin-5-yl)phenyl]amino]ethoxy]acetyl]-L-Aspartic acid | Anicancer therapy, prostate | amide | Sehgal, Inder;et.al (2008)
DOI | cpd01078 | 646065-65-8 | | GPLGIAGQ | Doxorubicin | Anticancer therapy | amide | Ryppa, Claudia;et.al (2008)
DOI | cpd01079 | 1022094-28-5 | | CTVALPGGYVRVCVXVX | Doxorubicin | Anticancer therapy (prodrug) | amide | Yoneda, Yoshiyuki;et.al (2008)
DOI | cpd01080 | 1022094-27-4 | | CTVALPGGYVRVCVXVX | Paclitaxel | Anticancer therapy (prodrug) | amide | Yoneda, Yoshiyuki;et.al (2008)
DOI | cpd01081 | 1008519-19-4 | | RGDFK | 3,4-dihydro-2,2,5,7,8-pentamethyl-2H-1-benzopyran-6-sulfonic acid | Synthesis | sulfonamide | Foillard, Stephanie;et.al (2008)
DOI | 
